Table 3.

Distribution of RAD51 genotype and allele frequencies in patients with triple- negative breast cancer and in control groups

	Patients with TNBC n = 70		Controls n = 70
172G/T	Number	(%)	Number	(%)	OR (95 % CI)a	p b
G/G	17	24	20	29	1.00 Ref
G/T	11	16	40	57	0.32 (0.13–0.82)	0.028
T/T	42	60	10	14	4.94 (1.91–12.71)	0.001
G	45	32	80	57	1.00 Ref
T	95	68	60	43	2.81 (1.72–4.58)	<.0001

Data in bold font are statistically significant

^aCrude odds ratio (OR), 95 % CI = confidence interval at 95 %

^bChi square